The effect of sex on the efficacy and safety of dual antithrombotic therapy with dabigatran versus triple therapy with warfarin after PCI in patients with atrial fibrillation (a RE‐DUAL PCI subgroup analysis and comparison to other dual antithrombotic therapy trials)

BACKGROUND: The RE‐DUAL PCI trial demonstrated that in patients with nonvalvular atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI), dual therapy with dabigatran and a P2Y(12) inhibitor, either clopidogrel or ticagrelor, reduced the risk of bleeding without an increased ris...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Cardiol
Main Authors: Eccleston, David S., Kim, Joseph M., ten Berg, Jurien M., Steg, P. Gabriel, Bhatt, Deepak L., Hohnloser, Stefan H., de Veer, Anne, Nordaby, Matias, Miede, Corinna, Kimura, Takeshi, Lip, Gregory Y. H., Oldgren, Jonas, Cannon, Christopher P.
Formato: Artigo
Idioma:Inglês
Publicado em: Wiley Periodicals, Inc. 2021
Assuntos:
Clinical Investigations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8259156/
https://ncbi.nlm.nih.gov/pubmed/34042199
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.23649
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados